Cannomed Medical Cannabis Industries Overview

  • Founded
  • 1999
Founded
  • Status
  • Public
  • Employees
  • 50
Employees
  • Stock Symbol
  • CNMD
Stock Symbol
  • Share Price
  • $0.22
  • (As of Thursday Closing)

Cannomed Medical Cannabis Industries General Information

Description

Cannomed Medical Cannabis Industries Ltd, formerly Proteologics Ltd is a biopharmaceutical company that discovers and develops novel therapeutics. It focuses on discovering inhibitors for E3 ubiquitin ligases. It offers novel drug for cancer, metabolic diseases, viral infection and CNS related disorders.

Contact Information

Formerly Known As
Proteologics
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
TAE
Primary Office
  • 8 Hamanofim
  • Herzliya 4672559
  • Israel
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cannomed Medical Cannabis Industries Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.22 $0.22 $0.19 - $0.43 $22M 99M 95.7K -$0.10

Cannomed Medical Cannabis Industries Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 12,721 12,721 7,955 3,858
Revenue 5,205 5,205 0 0
EBITDA (2,611) (2,611) (101) (350)
Net Income (2,559) (2,559) (252) (350)
Total Assets 15,712 15,712 3,615 3,851
Total Debt 4,721 4,721 3,845 41
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cannomed Medical Cannabis Industries Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cannomed Medical Cannabis Industries‘s full profile, request access.

Request a free trial

Cannomed Medical Cannabis Industries Executive Team (13)

Name Title Board Seat Contact Info
Zohar Shpitz Chief Financial Officer
Ilan Hyden General Manager
You’re viewing 2 of 13 executive team members. Get the full list »

Cannomed Medical Cannabis Industries Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cannomed Medical Cannabis Industries Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cannomed Medical Cannabis Industries‘s full profile, request access.

Request a free trial